ARCHIVES

FDA says new tools needed to speed therapeutics development.

This article is from The Cancer Letter archive.

Vol. 30 No. 13 | March 26, 2004

Download PDF Visit The Full Archive

Related Articles

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

March 21, 2003

Newcomers Undercut Price of BRCA Test; Myriad Lawsuits Claim Patent Infringement

July 25, 2013

FDA Faces Severe Regulatory, Scientific Needs, Report Finds.

February 1, 2008

Alcohol Consumption Does Not Impact Survival of Breast Cancer

April 26, 2013

With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies

May 22, 2009

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011